6th Annual
Clinical Trial
Innovation Summit
Innovation Summit
24 JUNE 2026 | BASEL | ROCHE BUILDING 1
PRESENTED BY
The Clinical Trial Innovation Summit returns to Roche Headquarters in Basel on 24 June 2026!
PanAgora Pharma and Roche are collaborating once again to bring the 6th Annual Clinical Trial Innovation Summit back to Basel this 24 June! This year's conference agenda will explore how life sciences organizations are delivering more patient-centric clinical trials and how digital health technologies (DHTs) are being implemented to improve efficacy measurement, patient recruitment, safety, and drug delivery.
Core themes and topics for the 2026 agenda include:
• Industry Trends and Innovations in Virtual, Hybrid and Decentralized Trials: AI, DHTs, Decentralized Trials, Evolving Role of CRO’s, Global Perspective
• Patient Perspective: Engagement, Involvement, and Applying Learnings at Scale
• Identifying Innovations & Technologies Accelerating Patient-Centric Trials
• Ideas into Action: Keys to Delivering Inclusive Human-Centered Clinical Trials
Join 35+ speakers and 250+ senior-level clinical research, operations, and trial design leaders on 24 June at Roche headquarters in Basel!
Core themes and topics for the 2026 agenda include:
• Industry Trends and Innovations in Virtual, Hybrid and Decentralized Trials: AI, DHTs, Decentralized Trials, Evolving Role of CRO’s, Global Perspective
• Patient Perspective: Engagement, Involvement, and Applying Learnings at Scale
• Identifying Innovations & Technologies Accelerating Patient-Centric Trials
• Ideas into Action: Keys to Delivering Inclusive Human-Centered Clinical Trials
Join 35+ speakers and 250+ senior-level clinical research, operations, and trial design leaders on 24 June at Roche headquarters in Basel!
Location
Date & Time
24 June 2026
08:45-18:00 Local Time (GMT+2)
Apéro to Follow
08:45-18:00 Local Time (GMT+2)
Apéro to Follow
HOST SPONSOR
AGENDA THEMES
1. Industry Trends in Unified Evidence:
Bridging Clinical Research and Real-World Data
2. Trial Design Optimization: Digital Twins, Agentic AI, Imaging, and Multi-Modal Intelligence
3. Accelerating Patient-Centric Trials and Technology
4. Beyond the Site: Omnichannel Engagement & Regulatory Strategy
Photos from Last Year's CTI Summit at Roche
SPEAKING FACULTY & ADVISORS
Paul Cooper
Personalised Healthcare Strategy Leader
Personalised Healthcare Strategy Leader
ROCHE
Ernst Jan Bos
Global Medical Director
Global Medical Director
ROCHE
Sandy Goss
Director of Digital Health Strategy
Director of Digital Health Strategy
ABBVIE
Nuno Valério
Head of Innovation, R&D Quality
Head of Innovation, R&D Quality
MERCK GROUP
Suki Balendra
Director of Strategic Partnerships
Director of Strategic Partnerships
IMPERIAL COLLEGE HEALTHCARE NHS TRUST
Piotr Maślak
Senior Director, Head of Emerging Technologies
Senior Director, Head of Emerging Technologies
ASTRAZENECA
Rea Lehner
Global Clinical Operations Excellence Leader
Global Clinical Operations Excellence Leader
ROCHE
Cristina Du Juan
Director, Product Management, Digital Health
Director, Product Management, Digital Health
UCB
Clara Cali Mella
Data Strategy Lead
Data Strategy Lead
BAYER
Abhishek Pratap
Executive Director, Global Evidence Lead
Executive Director, Global Evidence Lead
BOEHRINGER INGELHEIM
Vivide Chang
Imaging Lead
Imaging Lead
ROCHE
Mark Duman
Patient Engagement Pioneer
Patient Engagement Pioneer
MD HEALTHCARE
Iulia Brehueson
Global Accessibility Partner
Global Accessibility Partner
SANOFI
Steve Framil
Global Digital Accessbility Leader
Global Digital Accessbility Leader
(FMR) MERCK / ai1Y
Martina Endzhova
Global Category Lead for Clinical Development
Global Category Lead for Clinical Development
BAYER
Lauren Sunshine
Product Management, Digital Health Leader
Product Management, Digital Health Leader
(FMR) BMS
CoNFERENCE SCHEDULE
24 June 2026
08:30
Welcome Introduction
Paul Cooper, Therapeutic Area Lead, CVRM, DEPCS, Roche
Ernst Jan Bos, Global Medical Director, Roche
CONTENT BLOCK 1
INDUSTRY TRENDS
Unified Evidence: Bridging Clinical Research and Real-World Data
08:45
KEYNOTE PANEL DISCUSSION
Unified Evidence: Bridging Clinical Research and Real-World Data
Unified Evidence: Bridging Clinical Research and Real-World Data
This panel will look at the keys to integrating EHRs, Pragmatic Trials, and RWE to create a continuous feedback loop.
• Innovations in Design (AI/ML, Knowledge Management)
• Innovations in Execution (DHTs, Decentralized Trials, and Site Experience)
Panelists TBA
09:15
CASE STUDY
Protocol Simulations: An Innovative Way to Model Clinical Trials in the Real World
Protocol Simulations: An Innovative Way to Model Clinical Trials in the Real World
Clinical trials are inherently complex, with nearly 80% experiencing delays during execution. While most industries test products before launch, clinical trials are often initiated, sometimes globally, without prior real‑world validation. Protocol simulations address this gap by serving as a structured rehearsal of a clinical trial protocol in a real‑life setting providing actionable feedback.
Cristina De Juan, Clinical Innovation & Digital Solutions (CIDS) Lead, UCB
Cristina De Juan, Clinical Innovation & Digital Solutions (CIDS) Lead, UCB
09:35
CASE STUDY
AIMS-2-TRIALS: Autism Research for Europe
AIMS-2-TRIALS: Autism Research for Europe
Julian Tillmann, Clinical Scientist, Roche (pRED)
09:55
Presentation TBA
Speaker TBA
10:15
Networking Break
CONTENT BLOCK 2
TRIAL OPTIMIZATION
Innovations in Multi-Modal Intelligence, Digital Twins, Agentic AI, and Imaging
10:40
CASE STUDY
Scaling AI for Patient Impact in Clinical Trials
Scaling AI for Patient Impact in Clinical Trials
As clinical trials become more patient-centric, AI is shifting from pilots to production. This session examines scaling AI to improve patient experiences - reducing burden, enhancing safety monitoring, and enabling participation across decentralized and hybrid models. Focus on deployment realities: data integration, governance, regulatory compliance, and measuring impact beyond operational efficiency.
Piotr Maślak, Senior Director, Head of Emerging Technologies, AstraZeneca
11:00
CASE STUDY
Faster to First Insight: Leveraging Agentic AI to Unlock Strategic Options in Clinical Trial Design
Faster to First Insight: Leveraging Agentic AI to Unlock Strategic Options in Clinical Trial Design
This session will explore an agentic AI–powered decision support system that transforms how clinical trial feasibility and study design insights are generated, evaluated, and translated into strategic options. By orchestrating AI agents across data aggregation, analysis, and scenario evaluation, the system reduces manual effort, shortens insight cycles, and enables teams to explore multiple, evidence-backed development options earlier. This leads to faster, more robust, and better-aligned decision making.
Clara Cali Mella, Data Strategy Lead, Bayer
11:20
CASE STUDY
Delivering DCT Trials for Scale and Sustainability - A Case Study of Evidence in Practice
Delivering DCT Trials for Scale and Sustainability - A Case Study of Evidence in Practice
Dr. Michelle Longmire, Chief Executive Officer, Medable
11:40
CASE STUDY
The ROSA Experience:
Moving from Manual to AI-Assisted Image Grading in Ophthalmology to Unlock Novel Insights
The ROSA Experience:
Moving from Manual to AI-Assisted Image Grading in Ophthalmology to Unlock Novel Insights
Vivide Chang, Imaging Lead, Roche
12:00
PANEL
AI Imaging in Clinical Trials: Transforming Speed, Precision, and Decision-Making
AI Imaging in Clinical Trials: Transforming Speed, Precision, and Decision-Making
Sandy Goss, Director, Digital Health Strategy, AbbVie
Additional Panelists TBA
12:25
NETWORKING LUNCH
CONTENT BLOCK 3
PATIENT-CENTRIC TRIAL INNOVATION
Accelerating Patient-Centric Trials and Technologies
13:20
PATIENT PERSPECTIVE
An (im)Patient Perspective
An (im)Patient Perspective
Mark Duman, Patient Engagement Pioneer, MD Healthcare
13:40
SITE PERSPECTIVE
Omnichannel (Personalised) Clinical Trials. Going Beyond DCTs vs. On-Site
Omnichannel (Personalised) Clinical Trials. Going Beyond DCTs vs. On-Site
Suki Balendra, Director of Strategic Partnerships, Imperial College, NHS Trust
14:00
CASE STUDY
IHI READI
IHI READI
This session will explore the collaboration behind the IHI-funded project - IHI READI - aimed at fostering a more cohesive and integrated clinical studies ecosystem for underserved (US) and underrepresented (UR) communities.
Speaker TBA
14:20
PANEL
Trial Design Considerations: UX and Digital Accessibility
Trial Design Considerations: UX and Digital Accessibility
Diversity is a key success factor in clinical trials: advancing science and medicine through a variety of lived experiences and living conditions – particularly, people with disabilities. Digital accessibility design standards for patients with disabilities can be critical to clinical trial access, engagement, adherence, and measurement. With the Web Content Accessibility Guidelines (WCAG) design standards for Information & Communication Technologies (ICT), explore the WHY, the HOW, and the WHAT for digital accessibility in clinical trial diversity.
Iulia Brehuescu, Global Accessibility Partner, Sanofi
Lauren Sunshine, Director of Digital Health, (Fmr) Bristol Myers Squibb
Moderator: Dr. Stephen Framil, Global Head of Accessibility, (Fmr) Merck
14:55
NETWORKING BREAK
CONTENT BLOCK 4
BEYOND THE SITE
Omnichannel Engagement & Regulatory Strategy
15:20
CASE STUDY
Bridging the Cognitive Gap: How Novo Nordisk is Virtualizing Clinical Trial Decisions
Bridging the Cognitive Gap: How Novo Nordisk is Virtualizing Clinical Trial Decisions
Guillaume Carbonneau, Vice President of Operational Data Insights, Novo Nordisk
15:40
CASE STUDY
Delivering DCT Trials for Scale and Sustainability - A Case Study of Evidence in Practice
Delivering DCT Trials for Scale and Sustainability - A Case Study of Evidence in Practice
Alison Holland, Chief Customer Officer, Medable
16:00
CASE STUDY
Trust by Design: Building AI Governance That Earns Adoption
Trust by Design: Building AI Governance That Earns Adoption
AI governance in regulated environments often looks solid on paper but falls apart in practice — creating a gap where shadow AI thrives and real risk becomes invisible. This talk explores what governance looks like when you design it from both sides of the wall, drawing on hands-on experience building AI governance frameworks inside pharma R&D at Merck.
Nuno Valerio, Head of Innovation, R&D Quality, Merck
16:20
CASE STUDY
Hype, Evidence, and Regulatory Reality: Digital Health in CNS Clinical Development
Hype, Evidence, and Regulatory Reality: Digital Health in CNS Clinical Development
Abhi Pratap, Executive Director and Global Clinical Development Lead, Boehringer Ingelheim
16:35
CLOSING PANEL
Regulatory Strategy: DHTs in Clinical Trials - Reality Check and Key Takeaways
Regulatory Strategy: DHTs in Clinical Trials - Reality Check and Key Takeaways
Address the evolving regulatory landscape, highlighting strategies for maintaining compliance while enabling innovation.
Panelists TBA
17:00
Closing Reflection
Suki Balendra, Director of Strategic Partnerships, Paddington Life Sciences, Imperial College Healthcare NHS Trust
Ernst Jan Bos, Global Medical Director, Roche
17:05 - 18:30
APÉRO & NETWORKING RECEPTION!
Sponsors & Exhibitors (2025)
HOST SPONSOR
GOLD SPONSOR
GOLD SPONSOR
GOLD SPONSOR
GOLD SPONSOR
SILVER SPONSOR
EXHIBITOR
EXHIBITOR
EXHIBITOR
EXHIBITOR
EXHIBITOR
EXHIBITOR
EXHIBITOR
EXHIBITOR
EXHIBITOR
SUPPORTING SPONSOR
SUPPORTING SPONSOR
SUPPORTING SPONSOR
Media Partner
Interested in Sponsorship or
Exhibition Opportunities?
Exhibition Opportunities?
Conference Venue
Roche Tower (Building 1)
The Clinical Trials Innovation Summit (26 June) and the Digital Biomarkers Summit (25 June) will both be held in the Auditorium of Building 1 on the Roche campus in Basel.
Address:
Roche Tower (Building 1)
Grenzacherstrasse 124
4070 Basel, Switzerland
About: The office high-rise, Building 1, is a key pillar of Roche's site development strategy. With its straightforward yet unmistakable design, it blends in perfectly with the Roche grounds and the Basel cityscape. With 41 floors and workspace for around 2,000 employees, the office high-rise also shows a clear commitment to the Basel site.
Address:
Roche Tower (Building 1)
Grenzacherstrasse 124
4070 Basel, Switzerland
About: The office high-rise, Building 1, is a key pillar of Roche's site development strategy. With its straightforward yet unmistakable design, it blends in perfectly with the Roche grounds and the Basel cityscape. With 41 floors and workspace for around 2,000 employees, the office high-rise also shows a clear commitment to the Basel site.
Hotel Room Block
Hyperion Hotel Basel
(4 Star Hotel) Hyperion Hotel Basel in Basel, Switzerland
Location: Messepl. 12, 4058 Basel, Switzerland
In Basel's tallest habitable building, the HYPERION Hotel Basel is next to the Basel Messe trade fair center and just a short walk from the Old Town. It offers a sauna and a fitness center. Each of the 224 non-smoking guest rooms offers panoramic views of the city, free WiFi, air conditioning, refreshing bath products, a safe, hair dryer, and flat-screen TV with Sky channels.
PanAgora Pharma has a conference room block at the Hyperion Hotel Basel - just 1km from Roche Building 1. To book your room at the preferred room block rate, please use this link: CTIS Room Block at Hyperion Hotel Basel
UPDATE: The PanAgora Room Block will open on 15 March 2026 and close on 13 May 2026, but you can still use the link above to make a reservation at the Hyperion Hotel Basel. Once the room block reaches capacity, it is closed - so make sure to book as soon as possible!
